Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Celgene welcomes new CFO
June 1, 2018 Off

Celgene welcomes new CFO

By Dino Mustafić

Celgene Corporation has hired David V. Elkins as Executive Vice President (EVP), Chief Financial Officer (CFO), who will join the…

Sandoz receives positive CHMP opinion for proposed biosimilar adalimumab
June 1, 2018 Off

Sandoz receives positive CHMP opinion for proposed biosimilar adalimumab

By Dino Mustafić

Sandoz said Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has…

New CFO to join Bavarian Nordic
May 31, 2018 Off

New CFO to join Bavarian Nordic

By Dino Mustafić

Bavarian Nordic has appointed new Chief Financial Officer, coming from a Nasdaq Stockholm exchange listed pharmaceutical company, Orexo AB, it said…

Arix Biosciences director steps down
May 31, 2018 Off

Arix Biosciences director steps down

By Dino Mustafić

Arix Bioscience’s Non-Executive Director Lord Hutton is stepping down from his position, Arix said Thursday.

Boehringer Ingelheim’s Gilotrif dose adjustments helped improve patient tolerability in certain lung cancer
May 31, 2018 Off

Boehringer Ingelheim’s Gilotrif dose adjustments helped improve patient tolerability in certain lung cancer

By Dino Mustafić

Boehringer Ingelheim’s study showed that dose adjustment with Gilotrif helped improve patient tolerability while maintaining treatment efficacy and reduced the frequency…

Gilead, Galapagos’s joint psoriatic arthritis drug study meets primary endpoint. Announce Phase 3 for the selection Study in ulcerative colitis
May 31, 2018 Off

Gilead, Galapagos’s joint psoriatic arthritis drug study meets primary endpoint. Announce Phase 3 for the selection Study in ulcerative colitis

By Dino Mustafić

Gilead Sciences and Galapagos NV’s Phase 2 EQUATOR study of filgotinib, an investigational, selective JAK1 inhibitor, has achieved its primary…

FDA approves new treatment for moderately to severely active ulcerative colitis
May 31, 2018 Off

FDA approves new treatment for moderately to severely active ulcerative colitis

By Dino Mustafić

The U.S. Food and Drug Administration today expanded the approval of Pfizer’s Xeljanz (tofacitinib), the first oral medication approved for…

Hikma launches Methylergonovine Maleate tablets
May 30, 2018 Off

Hikma launches Methylergonovine Maleate tablets

By Dino Mustafić

Hikma Pharmaceuticals said that its wholly-owned US subsidiary, West-Ward Pharmaceuticals Corp. has launched Methylergonovine Maleate Tablets, USP, 0.2mg, the generic…

China Drug Administration approves Gilead’s chronic hepatitis C virus infection drug
May 30, 2018 Off

China Drug Administration approves Gilead’s chronic hepatitis C virus infection drug

By Dino Mustafić

Gilead Sciences has gotten the approval from the China Drug Administration (CDA) of Epclusa for the treatment of adults with…

FDA expedites review of Novartis drug Promacta for first-line severe aplastic anemia
May 30, 2018 Off

FDA expedites review of Novartis drug Promacta for first-line severe aplastic anemia

By Dino Mustafić

Novartis said Tuesday that the US Food and Drug Administration (FDA) has accepted the its supplemental New Drug Application (sNDA)…

Posts pagination

Previous 1 … 3,388 3,389 3,390 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine